Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma

[1] Rajkumar SV(2020)Multiple myeloma: 2020 update on diagnosis, risk-stratification and management Am J Hematol 95 548-567

[2] Bolzoni M(2016)Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target Blood 128 667-679

[3] Chiu M(2017)Role of Lancet Oncol 18 e206-e217

[4] Accardi F(2020)F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group Front Oncol 10 2956-2964

[5] Vescovini R(2017)PET/CT in multiple myeloma: beyond FDG Theranostics 7 23-31

[6] Airoldi I(2013)C-methionine-PET in multiple myeloma: a combined study from two different institutions PLoS ONE 8 56-63

[7] Storti P(2021)Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology Mol Cell 81 822-841

[8] Cavo M(2019)The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma Contemp Oncol (Pozn) 23 D1112-D1116

[9] Terpos E(2007)F-fluoro-ethyl-tyrosine ( J Nucl Med 48 46-55

[10] Nanni C(2019)F-FET) PET/CT as a potential new diagnostic tool in multiple myeloma: a preliminary study Radiographics 39 822-829

[1] Rajkumar SV(2020)Multiple myeloma: 2020 update on diagnosis, risk-stratification and management Am J Hematol 95 548-567

[2] Bolzoni M(2016)Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target Blood 128 667-679

[3] Chiu M(2017)Role of Lancet Oncol 18 e206-e217

[4] Accardi F(2020)F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group Front Oncol 10 2956-2964

[5] Vescovini R(2017)PET/CT in multiple myeloma: beyond FDG Theranostics 7 23-31

[6] Airoldi I(2013)C-methionine-PET in multiple myeloma: a combined study from two different institutions PLoS ONE 8 56-63

[7] Storti P(2021)Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology Mol Cell 81 822-841

[8] Cavo M(2019)The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma Contemp Oncol (Pozn) 23 D1112-D1116

[9] Terpos E(2007)F-fluoro-ethyl-tyrosine ( J Nucl Med 48 46-55

[10] Nanni C(2019)F-FET) PET/CT as a potential new diagnostic tool in multiple myeloma: a preliminary study Radiographics 39 822-829